192 related articles for article (PubMed ID: 26374221)
1. The Regulatory Pathway for Advanced Cell Therapy and Gene Therapy Products in Brazil: A Road to Be Built.
de Freitas DR
Adv Exp Med Biol; 2015; 871():213-9. PubMed ID: 26374221
[TBL] [Abstract][Full Text] [Related]
2. Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective.
Salmikangas P; Schuessler-Lenz M; Ruiz S; Celis P; Reischl I; Menezes-Ferreira M; Flory E; Renner M; Ferry N
Adv Exp Med Biol; 2015; 871():103-30. PubMed ID: 26374215
[TBL] [Abstract][Full Text] [Related]
3. Requirements for Clinical Trials with Gene Therapy and Transplant Products in Switzerland.
Marti A
Adv Exp Med Biol; 2015; 871():131-45. PubMed ID: 26374216
[TBL] [Abstract][Full Text] [Related]
4. United States Food and Drug Administration Regulation of Gene and Cell Therapies.
Bailey AM; Arcidiacono J; Benton KA; Taraporewala Z; Winitsky S
Adv Exp Med Biol; 2015; 871():1-29. PubMed ID: 26374210
[TBL] [Abstract][Full Text] [Related]
5. Regulatory Frameworks for Gene and Cell Therapies in Japan.
Maeda D; Yamaguchi T; Ishizuka T; Hirata M; Takekita K; Sato D
Adv Exp Med Biol; 2015; 871():147-62. PubMed ID: 26374217
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Clinical Trials with Advanced Therapy Medicinal Products in Germany.
Renner M; Anliker B; Sanzenbacher R; Schuele S
Adv Exp Med Biol; 2015; 871():87-101. PubMed ID: 26374214
[TBL] [Abstract][Full Text] [Related]
7. Regulatory Oversight of Cell- and Tissue-Based Therapeutic Products and Gene Therapy Products in Singapore.
Goh CW; Kellathur SN; Ong LL; Wu X
Adv Exp Med Biol; 2015; 871():195-212. PubMed ID: 26374220
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Cell and Gene Therapy Medicinal Products in Taiwan.
Lin YC; Wang PY; Tsai SC; Lin CL; Tai HY; Lo CF; Wu SI; Chiang YM; Liu LL
Adv Exp Med Biol; 2015; 871():181-94. PubMed ID: 26374219
[TBL] [Abstract][Full Text] [Related]
9. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Korea.
Choi M; Han E; Lee S; Kim T; Shin W
Adv Exp Med Biol; 2015; 871():163-79. PubMed ID: 26374218
[TBL] [Abstract][Full Text] [Related]
10. Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products.
Lucas-Samuel S; Ferry N; Trouvin JH
Adv Exp Med Biol; 2015; 871():73-85. PubMed ID: 26374213
[TBL] [Abstract][Full Text] [Related]
11. Regulatory Oversight of Cell and Gene Therapy Products in Canada.
Ridgway A; Agbanyo F; Wang J; Rosu-Myles M
Adv Exp Med Biol; 2015; 871():49-71. PubMed ID: 26374212
[TBL] [Abstract][Full Text] [Related]
12. Preface.
Galli MC
Adv Exp Med Biol; 2015; 871():v-vi. PubMed ID: 26677465
[No Abstract] [Full Text] [Related]
13. Should ANVISA be permitted to reject pharmaceutical patent applications in Brazil?
Mueller LL; Taketsuma Costa SM
Expert Opin Ther Pat; 2014 Jan; 24(1):1-4. PubMed ID: 24206261
[TBL] [Abstract][Full Text] [Related]
14. The National Institutes of Health Oversight of Human Gene Transfer Research: Enhancing Science and Safety.
O'Reilly M; Jambou R; Rosenthal E; Montgomery M; Hassani M; Gargiulo L; Corrigan-Curay J
Adv Exp Med Biol; 2015; 871():31-47. PubMed ID: 26374211
[TBL] [Abstract][Full Text] [Related]
15. Main Reasons for Registration Application Refusal of Generic and Similar Pharmaceutical Drug Products by the Brazilian Health Regulatory Agency (ANVISA).
do Carmo AC; Piras SS; Rocha NF; Gratieri T
Biomed Res Int; 2017; 2017():7894937. PubMed ID: 28280742
[No Abstract] [Full Text] [Related]
16. Ethical considerations in the application of cell and gene therapies in children.
Pepper MS; Pope A; Kling S; Alessandrini M; Van Staden W; Green RJ
S Afr Med J; 2018 Nov; 108(12):1027-1029. PubMed ID: 30606284
[TBL] [Abstract][Full Text] [Related]
17. Advanced Therapy Products in Brazil: Regulatory Aspects.
Junior JBS; Parca RM; Carvalho AB
Adv Exp Med Biol; 2023; 1430():117-133. PubMed ID: 37526845
[TBL] [Abstract][Full Text] [Related]
18. [Clinical trials with advanced therapy medicinal products].
Schüssler-Lenz M; Schneider CK
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):68-74. PubMed ID: 20011994
[TBL] [Abstract][Full Text] [Related]
19. A few ethical issues in translational research for gene and cell therapy.
Riva L; Petrini C
J Transl Med; 2019 Nov; 17(1):395. PubMed ID: 31779636
[TBL] [Abstract][Full Text] [Related]
20. Report of the International Regulatory Forum on Human Cell Therapy and Gene Therapy Products.
Hayakawa T; Harris I; Joung J; Kanai N; Kawamata S; Kellathur S; Koga J; Lin YC; Maruyama Y; McBlane J; Nishimura T; Renner M; Ridgway A; Salmikangas P; Sakamoto N; Sato D; Sato Y; Toda Y; Umezawa A; Werner M; Wicks S
Biologicals; 2016 Sep; 44(5):467-79. PubMed ID: 27461129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
